A.R.T. Advisors’s Collegium Pharmaceutical COLL Stock Holding History

A.R.T. Advisors’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-46,187	Closed	-$951K	–	251
2019 Q4	$951K	Buy	+46,187	New	+$770K	0.05%	582
2019 Q3	–	Sell	-17,387	Closed	-$229K	–	1473
2019 Q2	$229K	Sell	17,387 -39,112	-69%	-$523K	0.01%	1054
2019 Q1	$855K	Buy	56,499 +40,800	+260%	+$653K	0.05%	537
2018 Q4	$270K	Sell	15,699 -20,281	-56%	-$347K	0.02%	965
2018 Q3	$530K	Sell	35,980 -52,814	-59%	-$936K	0.02%	838
2018 Q2	$2.12M	Buy	88,794 +35,500	+67%	+$873K	0.09%	346
2018 Q1	$1.36M	Sell	53,294 -34,500	-39%	-$822K	0.05%	540
2017 Q4	$1.62M	Buy	87,794 +67,500	+333%	+$967K	0.07%	446
2017 Q3	$212K	Buy	+20,294	New	+$224K	0.01%	1114
2016 Q3	–	Sell	-12,500	Closed	-$148K	–	737
2016 Q2	$148K	Buy	+12,500	New	+$206K	0.01%	1157

Other funds holding COLL

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

A.R.T. Advisors's COLL Position: Q1 2020 in Review

A.R.T. Advisors sold out of Collegium Pharmaceutical (COLL) in Q1 2020, closing a stake of 46,187 shares — an estimated $951K sold.

A.R.T. Advisors first reported a position in COLL in Q2 2016 and held it in 10 quarters. The position peaked at $2.12M in Q2 2018. 159 funds tracked by Wall St. Rank hold COLL as of Q1 2020.

A.R.T. Advisors reported no remaining Collegium Pharmaceutical position as of Q1 2020 after selling out during the quarter.
A.R.T. Advisors sold 46,187 Collegium Pharmaceutical shares in Q1 2020, an estimated $951K.
A.R.T. Advisors first reported a position in Collegium Pharmaceutical in Q2 2016 and held it in 10 quarters.
A.R.T. Advisors's Collegium Pharmaceutical position peaked at $2.12M in Q2 2018.
159 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.